Xgenera is dedicated to transforming cancer diagnosis through their groundbreaking multi-cancer early detection (MCED) test. With a mission to save lives by identifying cancer at its earliest stages, Xgenera leverages cutting-edge technology and advanced algorithms to detect a wide range of cancers with exceptional accuracy. By detecting cancer earlier, when treatment options are most effective, Xgenera aims to improve patient outcomes and ultimately reduce the global burden of cancer. Backed by data from large patient cohorts and ongoing research, Xgenera's MCED test holds the potential to revolutionise cancer diagnosis around the world. With a commitment to empowering individuals and healthcare providers with timely, actionable information, Xgenera is at the forefront of the fight against cancer, paving the way for a future where early detection saves lives.
| Website | https://www.xgenera.com/ |
| Employees | 7 (5 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Early Cancer Detection, Cancer Diagnostics, Cancer Screening, Cancer Detection Technology, Oncology Diagnostics, Molecular Diagnostics, Medical Diagnostics, Cancer Biomarkers, Diagnostic Testing, Clinical Diagnostics, Liquid Biopsy, Disease Diagnostics, In Vitro Diagnostics, Precision Oncology, Medical Technology, Healthcare Technology, Cancer Research, Biotechnology |
Looking for a particular Xgenera employee's phone or email?
Andy Shapanis is the CEO of Xgenera.
5 people are employed at Xgenera.